Category: Clinical Trials
Clinical trials of integrative medicine: testing whether magic works?
I just thought that I’d take the editor’s (and, speaking for Steve, the founder’s) prerogative to promote our own efforts. Regular readers of SBM are familiar with our message with respect to randomized clinical trials of highly implausible “complementary and alternative medicine” treatments, such as homeopathy or reiki. Well, believe it or not, Steve and I managed to get a commentary...
“Atavistic oncology” revisited: Dr. Frank Arguello responds
Three weeks ago, I wrote about a cancer treatment promoted by Dr. Frank Arguello that I deemed to be quackery, launching into one of my usual discussions based in science (and with a touch of snark) regarding why. Dr. Arguello, it appears, is not very happy about what I wrote. So he responded. He also sent e-mails complaining to my cancer center...
The Texas Medical Board vs. Stanislaw Burzynski, 2014 edition
Here we go again. I'll give the Texas Medical Board credit for one thing. It's persistent. It's going after Stanislaw Burzynski's medical license again. Will this finally be the time the TMB puts a stop to Burzynski's abuse of the clinical trial process and patients? Or will this be a replay of the 1990s, with Burzynski slithering away yet again?
Consortium of Academic Health Centers for Integrative Medicine research conference disappoints even NCCAM
In May, the International Research Congress on Integrative Medicine and Health (IRCIMH) conference was held in Miami. In the words of its website, the conference was “convened by” the Consortium of Academic Health Centers for Integrative Medicine (CAHCIM), “in association with” the International Society for Complementary Medicine Research. As CAHCIM chirped in this tweet: “Three days, 22 countries, 100 academic medical institutions,...
The Center for Inquiry weighs in on the FDA’s mishandling of Stanislaw Burzynski’s clinical trials
The Center for Inquiry points out how what Stanislaw Burzynski is doing corrupts the clinical trial process and harms patients.
Beware The P-Value
The p-value was meant to be used as a convenient and quick test to evaluate how likely a result was due to chance, or a real effect. It has since come to be treated as an indication of importance or truth, particularly in the CAM world. This is a problem.
Stanislaw Burzynski’s propaganda victory on antineoplastons: The FDA really caves
Once more, the FDA fails to shut down Stanislaw Burzynski's clinic and antineoplaston manufacturing operation. Cancer patients will suffer as a result of the FDA's failure.
Did Facebook and PNAS violate human research protections in an unethical experiment?
Ed. Note: NOTE ADDENDUM I daresay that I’m like a lot of you in that I spend a fair bit of time on Facebook. This blog has a Facebook page (which, by the way, you should head on over and Like immediately). I have a Facebook page, several of our bloggers, such as Harriet Hall, Steve Novella, Mark Crislip, Scott Gavura, Paul...
Acupuncture for Macular Degeneration: Why I Reject the Evidence
This post is dedicated to two people who are frequent commenters on SBM, Stephen S. Rodrigues and Peter Moran. Rodrigues is an MD/acupuncturist who tries to persuade us that acupuncture is effective. Moran is a retired surgeon who objects to insulting language and thinks more can be accomplished by trying to better understand why people turn to CAM and by explaining the...
Macular Degeneration and AREDS 2 Supplements
Four years ago I wrote about the premature marketing of a diet supplement for macular degeneration before the results of a trial to test it were available. Now that we know the results of that trial, a follow-up post is in order. Age-related macular degeneration (AMD) is a leading cause of blindness. The incidence increases with age; it affects 10% of people...